DFB Healthcare Acquisitions Corp.

Equities

AHCO

US23291E1091

Delayed Nasdaq 11:18:46 2021-10-05 am EDT 5-day change 1st Jan Change
23.49 USD -0.29% Intraday chart for DFB Healthcare Acquisitions Corp. -0.88% -37.27%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
UBS Adjusts AdaptHealth Price Target to $13 From $9, Maintains Buy Rating MT
Deutsche Bank Adjusts AdaptHealth Price Target to $10 From $8, Maintains Hold Rating MT
AdaptHealth's Q4 Loss Widens, Revenue Rises; Provides 2024 Revenue Guidance; Shares Climb MT
Earnings Flash (AHCO) ADAPTHEALTH Posts Q4 Revenue $858.2M, vs. Street Est of $825.5M MT
UBS Trims AdaptHealth Price Target to $9 From $10, Maintains Buy Rating MT
UBS Adjusts AdaptHealth Price Target to $10 From $18, Maintains Buy Rating MT
BofA Securities Downgrades AdaptHealth to Underperform From Neutral, Adjusts Price Target to $6.50 From $9.50 MT
AdaptHealth Facing Headwinds Due to Slower-Than-Expected Patient Transitions, BofA Says MT
Deutsche Bank Adjusts AdaptHealth Price Target to $8 From $14, Maintains Hold Rating MT
RBC Cuts Price Target on AdaptHealth to $13 From $18, Keeps Outperform Rating MT
Earnings Flash (AHCO) ADAPTHEALTH Reports Q3 Revenue $804M, vs. Street Est of $796.6M MT
BofA Securities Adjusts AdaptHealth's Price Target to $11 From $13, Keeps Neutral Rating MT
AdaptHealth Chief Executive Officer Steps Down MT
AdaptHealth's New CEO Gets Court Order Preventing Him From Assuming Role Until Oct. 15 MT
Sector Update: Health Care Stocks Slipping Late Afternoon MT
Sector Update: Health Care MT
AdaptHealth Shares Decline as Newly Appointed CEO Faces Lawsuit Over Alleged Trade-Secrets Concerns MT
Deutsche Bank Raises AdaptHealth Price Target to $14 From $11.30, Maintains Hold Rating MT
UBS Adjusts AdaptHealth Price Target to $18 From $15, Maintains Buy Rating MT
AdaptHealth's Q2 Earnings Flat, Revenue Rises; 2023 Revenue Guidance Tops Street View; Shares Rise MT
Earnings Flash (AHCO) ADAPTHEALTH Reports Q2 Revenue $793.3M, vs. Street Est of $765.2M MT
Alignment Healthcare Names Christopher Joyce Chief Legal and Administrative Officer MT
Baird Adjusts Price Target on AdaptHealth to $21 From $20, Maintains Outperform Rating MT
AdaptHealth Names Crispin Teufel Chief Executive MT
RBC Cuts Price Target on AdaptHealth to $18 From $24 After Q1 Miss, Notes Unexpected Weakness in Diabetes, Keeps Outperform Rating MT
Chart DFB Healthcare Acquisitions Corp.
More charts
  1. Stock
  2. Equities
  3. Stock DFB Healthcare Acquisitions Corp. - Nasdaq
  4. News DFB Healthcare Acquisitions Corp.
  5. DFB Healthcare Acquisitions : AdaptHealth Q4 Loss Widens; Revenue More than Doubles; Boosts 2021 Revenue Outlook